vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and STRATUS PROPERTIES INC (STRS). Click either name above to swap in a different company.

IRIDEX CORP is the larger business by last-quarter revenue ($14.7M vs $8.3M, roughly 1.8× STRATUS PROPERTIES INC). On growth, STRATUS PROPERTIES INC posted the faster year-over-year revenue change (-19.4% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs -44.1%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

Ryman Hospitality Properties, Inc. is a hotel, resort, entertainment, and media company named for one of its assets: the Ryman Auditorium, a National Historic Landmark in Nashville, Tennessee. The company's legal lineage can be traced back to its time as a subsidiary of Edward Gaylord's Oklahoma Publishing Company; however, the backbone of the modern entity was formed with the company's acquisition of WSM, Inc. in 1983. This purchase resulted in the ownership of the Grand Ole Opry and associa...

IRIX vs STRS — Head-to-Head

Bigger by revenue
IRIX
IRIX
1.8× larger
IRIX
$14.7M
$8.3M
STRS
Growing faster (revenue YoY)
STRS
STRS
+50.3% gap
STRS
-19.4%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
-44.1%
STRS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRIX
IRIX
STRS
STRS
Revenue
$14.7M
$8.3M
Net Profit
$16.9M
Gross Margin
37.2%
Operating Margin
Net Margin
203.2%
Revenue YoY
-69.7%
-19.4%
Net Profit YoY
1293.4%
EPS (diluted)
$2.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
STRS
STRS
Q4 25
$14.7M
$8.3M
Q3 25
$12.5M
$5.0M
Q2 25
$13.6M
$11.6M
Q1 25
$11.9M
$5.0M
Q4 24
$12.7M
$10.3M
Q3 24
$11.6M
$8.9M
Q2 24
$12.6M
$8.5M
Q1 24
$11.8M
$26.5M
Net Profit
IRIX
IRIX
STRS
STRS
Q4 25
$16.9M
Q3 25
$-1.6M
$-8.0M
Q2 25
$-994.0K
$-2.3M
Q1 25
$-1.7M
$-3.8M
Q4 24
$-834.0K
$-1.4M
Q3 24
$-1.9M
$-1.4M
Q2 24
$-2.7M
$-2.8M
Q1 24
$-3.5M
$3.7M
Gross Margin
IRIX
IRIX
STRS
STRS
Q4 25
37.2%
Q3 25
32.1%
-85.1%
Q2 25
34.5%
-19.0%
Q1 25
42.5%
5.1%
Q4 24
44.0%
18.3%
Q3 24
37.3%
2.5%
Q2 24
40.7%
10.9%
Q1 24
37.9%
30.7%
Operating Margin
IRIX
IRIX
STRS
STRS
Q4 25
Q3 25
-11.3%
-162.9%
Q2 25
-6.9%
-6.5%
Q1 25
-1.7%
-71.3%
Q4 24
-3.9%
-13.6%
Q3 24
-16.1%
-17.1%
Q2 24
-20.9%
-34.4%
Q1 24
-28.0%
13.9%
Net Margin
IRIX
IRIX
STRS
STRS
Q4 25
203.2%
Q3 25
-12.6%
-161.1%
Q2 25
-7.3%
-19.8%
Q1 25
-14.2%
-74.5%
Q4 24
-6.6%
-13.7%
Q3 24
-16.7%
-15.9%
Q2 24
-21.2%
-32.7%
Q1 24
-29.5%
13.9%
EPS (diluted)
IRIX
IRIX
STRS
STRS
Q4 25
$2.42
Q3 25
$-0.09
$-0.62
Q2 25
$-0.06
$0.03
Q1 25
$-0.10
$-0.36
Q4 24
$-0.05
$-0.06
Q3 24
$-0.12
$-0.05
Q2 24
$-0.16
$-0.21
Q1 24
$-0.21
$0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
STRS
STRS
Cash + ST InvestmentsLiquidity on hand
$6.0M
$74.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$204.5M
Total Assets
$29.2M
$563.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
STRS
STRS
Q4 25
$6.0M
$74.3M
Q3 25
$5.6M
$55.0M
Q2 25
$6.8M
$59.4M
Q1 25
$7.2M
$12.0M
Q4 24
$2.4M
$20.2M
Q3 24
$3.9M
$19.6M
Q2 24
$4.1M
$13.5M
Q1 24
$5.4M
$20.7M
Total Debt
IRIX
IRIX
STRS
STRS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
IRIX
IRIX
STRS
STRS
Q4 25
$204.5M
Q3 25
$4.7M
$185.8M
Q2 25
$6.1M
$191.9M
Q1 25
$852.0K
$191.5M
Q4 24
$2.1M
$194.7M
Q3 24
$2.6M
$196.4M
Q2 24
$4.2M
$196.3M
Q1 24
$6.5M
$197.6M
Total Assets
IRIX
IRIX
STRS
STRS
Q4 25
$29.2M
$563.4M
Q3 25
$28.4M
$572.6M
Q2 25
$31.6M
$574.8M
Q1 25
$34.2M
$534.6M
Q4 24
$29.1M
$532.6M
Q3 24
$30.2M
$523.2M
Q2 24
$31.2M
$514.0M
Q1 24
$34.1M
$509.5M
Debt / Equity
IRIX
IRIX
STRS
STRS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRIX
IRIX
STRS
STRS
Operating Cash FlowLast quarter
$-29.9M
Free Cash FlowOCF − Capex
$-38.0M
FCF MarginFCF / Revenue
-458.5%
Capex IntensityCapex / Revenue
98.2%
Cash ConversionOCF / Net Profit
-1.77×
TTM Free Cash FlowTrailing 4 quarters
$-70.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRIX
IRIX
STRS
STRS
Q4 25
$-29.9M
Q3 25
$-1.2M
$-9.0M
Q2 25
$-397.0K
$-1.7M
Q1 25
$-1.1M
$-13.5M
Q4 24
$-1.2M
$-5.8M
Q3 24
$-3.1M
$-686.0K
Q2 24
$-1.3M
$-8.3M
Q1 24
$-1.6M
$6.5M
Free Cash Flow
IRIX
IRIX
STRS
STRS
Q4 25
$-38.0M
Q3 25
$-1.2M
$-9.9M
Q2 25
$-410.0K
$-4.3M
Q1 25
$-1.2M
$-18.0M
Q4 24
$-1.2M
$-35.0M
Q3 24
$-3.1M
$-7.5M
Q2 24
$-16.3M
Q1 24
$-1.7M
$-1.6M
FCF Margin
IRIX
IRIX
STRS
STRS
Q4 25
-458.5%
Q3 25
-9.4%
-198.7%
Q2 25
-3.0%
-37.2%
Q1 25
-9.8%
-357.4%
Q4 24
-9.8%
-339.7%
Q3 24
-26.5%
-84.4%
Q2 24
-191.6%
Q1 24
-14.0%
-6.0%
Capex Intensity
IRIX
IRIX
STRS
STRS
Q4 25
98.2%
Q3 25
0.1%
18.4%
Q2 25
0.1%
22.7%
Q1 25
0.1%
89.8%
Q4 24
0.1%
283.0%
Q3 24
0.0%
76.7%
Q2 24
0.0%
94.2%
Q1 24
0.0%
30.7%
Cash Conversion
IRIX
IRIX
STRS
STRS
Q4 25
-1.77×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
1.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons